+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine



Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine



European Journal of Histochemistry 41(Suppl. 2): 29-30




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973989

Download citation: RISBibTeXText

PMID: 9859769


Related references

Functional and phenotypic studies on leukemic t cells from acute lymphoblastic leukaemia. Indian Journal of Medical Research 88(DEC): 493-504, 1989

Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia. Clinical and Experimental Dermatology 32(2): 151-154, 2007

Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia. British Journal of Haematology 126(4): 623-624, 2004

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia. Case Reports in Hepatology 2011: 258791, 2011

Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia. Case Reports in Hepatology 2011: 1-3, 2011

Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells. International Journal of Hematology 85(2): 108-115, 2007

Clinical Efficacy of Immunochemotherapy with Fludarabine, Epirubicin and Rituximab FER in the Treatment of Chronic Lymphocytic Leukaemia and Prolymphocytic Leukaemia. 2011

Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia. European Journal of Haematology 87(5): 426-433, 2011

Monoclonal immunoproliferative disorder of B-lymphocytes IgD/lambda changing from chronic lymphocytic leukaemia to myeloma and plasmacytic leukaemia pattern. Acta Haematologica 68(2): 105-108, 1982

Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine. British Journal of Haematology 139(3): 349-349, 2007

Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine. Journal of Clinical Pathology 48(2): 181-182, 1995

Phenotypic alteration of leukemic hairy cells upon interferon alpha treatment in vitro. Journal of Cancer Research & Clinical Oncology 111(Suppl.): S40, 1986

Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia. Jpma. Journal of the Pakistan Medical Association 56(1): 44-45, 2006

Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial. Lancet. Oncology 12(13): 1204-1213, 2011

Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells. Leukemia 15(1): 69-73, 2001